The professional divide on Tendulkar's estimation goes a long way back A committee is being set up to devise yet another methodology to estimate poverty in India. The step has led to some unhappiness among economists and experts that it amounts to junking the services and competence of an expert like the late Suresh Tendulkar, whose study is sought to be replaced. Under pressure from all sides over its estimate of people...

-The Hindu    “Population aged 60 and above will grow to 17% by 2050” The World Health Organisation (WHO) in partnership with the Union Ministry of Health & Family Welfare has called for greater attention to the aging of India's population, its implications for health policy and for promotion of a society where the elderly can live full, enriching and productive lives. “In India, as all around the world, people are living longer. Undoubtedly...

The change is accompanied by a significant geographical shift from the south and north-east to states in other parts of India such as Maharashtra, Bihar, Orissa and Rajasthan Marking a dramatic shift in the demographic profile of people with AIDS, migrant workers and their wives have emerged as a high-risk group (HRG) for contracting the human immunodeficiency virus (HIV), with an infection rate surpassing that of injecting drug users, commercial sex...

-Reuters   Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital.  "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...